The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
Kuriata-Kordek
M
M
Department of Nephrology and Transplant Medicine, Wrocław Medical University, Poland.
Boratyńska
M
M
Klinger
M
M
Woźniak
M
M
Urbaniak
J
J
Szyber
P
P
Patrzalek
D
D
Tupka
D
D
D000208:Acute Disease; D000328:Adult; D019540:Area Under Curve; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D007970:Leukopenia / Q000453:epidemiology; D008297:Male; D008657:Metabolic Clearance Rate; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000097:blood* / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid